502P Nivolumab, alone or with ipilimumab, for mismatch repair deficient metastatic colorectal cancer: A United Kingdom multicentre analysis of patient outcomes

J J M Lam, J Bridgewater, M Alani, S Mullamitha, M Braun, V Kunene, S Baijal, C Holden, K Aboud, N Chopra, C Lopez Escola, A Rao, Leslie Samuel, A Denton, S A Grumett, L Melcher, S Muthuramalingam, P Sankey, M Saunders, K-K Shiu

Research output: Chapter in Book/Report/Conference proceeding › Published conference contribution

Fingerprint

Dive into the research topics of '502P Nivolumab, alone or with ipilimumab, for mismatch repair deficient metastatic colorectal cancer: A United Kingdom multicentre analysis of patient outcomes'. Together they form a unique fingerprint.

Medicine & Life Sciences